Stockholders' Equity - Warrant Activity Including Activity Related To Pre-funded Warrants (Detail) |
6 Months Ended |
---|---|
Jun. 30, 2022
$ / shares
shares
| |
Pre-funded Warrants [Member] | |
Number of Other than Option Shares | |
Outstanding, Beginning | 2,300,000 |
Issued | 24,379,673 |
Exercised | (2,300,000) |
Outstanding, Ending | 24,379,673 |
Common Stock Warrant [Member] | |
Number of Other than Option Shares | |
Outstanding, Beginning | 18,302,244 |
Exercised | (4,299,270) |
Outstanding, Ending | 14,002,974 |
Warrant [Member] | |
Number of Other than Option Shares | |
Outstanding, Beginning | 20,602,244 |
Issued | 24,379,673 |
Exercised | (6,599,270) |
Outstanding, Ending | 38,382,647 |
Weighted Average Exercise Price | |
Outstanding, Beginning | $ / shares | $ 1.22 |
Issued | $ / shares | 0.001 |
Exercised | $ / shares | 1.37 |
Outstanding, Ending | $ / shares | $ 0.50 |
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|